Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Loperamide hydrochloride
PCO Manufacturing Ltd.
A07DA; A07DA03
Loperamide hydrochloride
2 milligram(s)
Orodispersible tablet
Product not subject to medical prescription
Antipropulsives; loperamide
Authorised
2012-08-31
_ _ _ _ _ _ _ _ PACKAGE LEAFLET: INFORMATION FOR THE PATIENT IMODIUM ® INSTANTS 2 MG ORODISPERSIBLE TABLETS loperamide hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always use this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you. ▪ This medicine is available without prescription and is used to treat sudden short-lived (acute) attacks of diarrhoea in adults and children aged 12 years and over. ▪ Keep this leaflet. You may need to read it again. ▪ Ask your pharmacist if you need more information or advice. ▪ If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4 ►. ▪ You must talk to a doctor if you do not feel better or if you feel worse after 24 hours. WHAT IS IN THIS LEAFLET 1. What IMODIUM Instants is and what it is used for 2. What you need to know before you take IMODIUM Instants 3. How to take IMODIUM Instants 4. Possible side effects 5. How to store IMODIUM Instants 6. Contents of the pack and other information 1. WHAT IMODIUM INSTANTS IS AND WHAT IT IS USED FOR IMODIUM Instants is a medicine which is used to treat sudden short-lived (acute) attacks of diarrhoea in adults and children aged 12 years and over. The tablets contain loperamide hydrochloride which helps reduce diarrhoea by slowing down an overactive bowel, which helps the body to absorb water and salts from the bowel. IMODIUM Instants should be used in conjunction with oral rehydration therapy which replace fluids and salts lost during diarrhoea. You must talk to a doctor if you do not feel better or if you feel worse after 24 hours in case of acute diarrhoea. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE IMODIUM INSTANTS This medicine is suitable for most people, but a few people should not use it. If you are in any doubt, talk to your doctor or pharmacist. DO NOT TAKE IMODIUM INSTANTS… ▪ If you are allergic to loperamide or any of Read the complete document
Health Products Regulatory Authority 25 April 2023 CRN00DHKT Page 1 of 2 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Imodium Instants 2 mg Orodispersible Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Loperamide hydrochloride 2 mg per tablet. Excipient(s) with known effect: Aspartame (E951) and the Mint flavouring contains traces of Sulphites For the full list of excipients see section 6.1 3 PHARMACEUTICAL FORM Orodispersible tablet. _Product imported from Greece and Poland._ White to off-white, circular, freeze-dried tablets. 4 CLINICAL PARTICULARS As per PA0330/045/001 5 PHARMACOLOGICAL PROPERTIES As per PA0330/045/001 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Gelatin Mannitol (E421) Aspartame (E951) Sodium hydrogen carbonate Mint flavor 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf life expiry date of this product shall be the date shown on the container and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 30 °C. Store in the original container. 6.5 NATURE AND CONTENTS OF CONTAINER Blister packs of 6 or 12 tablets in a printed cardboard carton. Not all pack sizes may be marketed. Health Products Regulatory Authority 25 April 2023 CRN00DHKT Page 2 of 2 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER PCO Manufacturing Ltd. Unit 10, Ashbourne Business Park Rath Ashbourne Co. Meath Ireland 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA0465/001/002 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 31 st August 2012 10 DATE OF REVISION OF THE TEXT April 2023 Read the complete document